Chemotherapy only

DRUG5 trials

Sponsors

Samsung Medical Center, University of Leicester, Centre Francois Baclesse, Tang-Du Hospital, Nonhlanhla P Khumalo

Conditions

Cancer Skin and Connective Tissue DiseasesColonic CancerMetastasisNSCLC Patients With EGFR Activating MutationNon-small Cell Lung Cancer

Phase 1

Combining Curcumin With FOLFOX Chemotherapy in Patients With Inoperable Colorectal Cancer

CompletedNCT01490996

University of LeicesterColonic Cancer, Metastasis

Start: 2012-02-29End: 2017-05-31Updated: 2020-01-31

Phase 2

Adjuvant CCRT vs CT in Minimal N2 NSCLC

CompletedNCT01066234

Samsung Medical CenterNon-small Cell Lung Cancer

Start: 2017-10-23End: 2021-01-18Updated: 2021-03-22

Phase 3

A Multicenter Randomized Phase III Study Comparing Second-line Treatment With Chemotherapy Associated or Not to Erlotinib in NSCLC Patients With Secondary Resistance to TKI-EGFR

TerminatedNCT02178397

Centre Francois BaclesseNSCLC Patients With EGFR Activating Mutation

Start: 2014-06-30End: 2015-09-30Updated: 2017-07-17

Does hair curl variation influence the efficacy of scalp cooling in the prevention of chemotherapy-induced alopecia in breast cancer patients? A randomised pilot trial

Active, not recruitingPACTR202104554144365

Nonhlanhla P KhumaloCancer Skin and Connective Tissue Diseases

Start: 2017-01-16Target: 52Updated: 2026-01-27

Unknown Phase

A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC

Not yet recruitingNCT06503042

Tang-Du HospitalNon-small Cell Lung Cancer

Start: 2024-08-01End: 2026-08-01Target: 100Updated: 2024-07-16

Related Papers

Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial.

2019-07-01179 citations

Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial

Trials2015-03-2369 citations